Effect of age and gender on citalopram and desmethylcitalopram steady-state plasma concentrations in adults and elderly depressed patients

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 29, Issue 6, 2005, Pages 952-956

  De Mendonça Lima, Carlos A ^a   Baumann, Pierre ^b   Brawand Amey, Marlyse ^b   Brogli, Christian ^b   Jacquet, Sylvie ^b   Cochard, Nathalie ^b   Powell Golay, Kerry ^c   Eap, Chin B ^b  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b Hopital de Cery   (Switzerland)

^c NONE

Author keywords

Body mass index or BMI; Citalopram; Depressive patients; Elderly; Gender; Plasma concentrations

Indexed keywords

CITALOPRAM; NORCITALOPRAM;

ADULT; AGED; AGING; ARTICLE; BODY MASS; CONTROLLED STUDY; CORRELATION ANALYSIS; DEPRESSION; DOSE RESPONSE; DRUG BLOOD LEVEL; FEMALE; HUMAN; KIDNEY FUNCTION; LIVER FUNCTION; MAJOR CLINICAL STUDY; MALE; SEX DIFFERENCE;

AGED; AGED, 80 AND OVER; AGING; ANTIDEPRESSIVE AGENTS; CITALOPRAM; DEPRESSION; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; HUMANS; IMIPRAMINE; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SEX CHARACTERISTICS;

EID: 23144454933     PISSN: 02785846     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2005.06.001     Document Type: Article

References (18)

1. P. Baumann, and F. Larsen Die Pharmakokinetik von Citalopram Rev. Contemp. Pharmacother. 6 1995 G17 G26
2. P. Baumann, D.F. Zullino, and C.B. Eap Enantiomers' potential in psychopharmacology-a critical analysis with special emphasis on the antidepressant escitalopram Eur. Neuropsychopharmacol. 12 2003 433 444
3. K. Brøsen, and C.A. Naranjo Review of pharmacokinetic and pharmacodynamic interaction studies with citalopram Eur. Neuropsychopharmacol. 11 2001 275 283
4. C. De Mendonça Lima, W. Pertoldi, A. Delgado, and N. Renson Evaluation de l'état nutritionnel des patients dans un hôpital de jour psychogériatrique Age and Nutrition 10 1999 9 13
5. C.B. Eap, G. Bouchoux, M. Amey, N. Cochard, L. Savary, and P. Baumann Simultaneous determination of human plasma levels of citalopram, paroxetine, sertraline, and their metabolites by gas chromatography-mass spectrometry J. Chromatogr. Sci. 36 1998 365 371
6. J.P. Foglia, B.G. Pollock, M.A. Kirshner, J. Rosen, R. Sweet, and B. Mulsant Plasma levels of citalopram enantiomers and metabolites in elderly patients Psychopharmacol. Bull. 33 1997 109 112
7. M. Gutierres, and W. Abramowitz Steady-state pharmacokinetics of citalopram in young and elderly subjects Pharmacotherapy 20 2000 1441 1447
8. V. Jagadeesan, and K. Krishnaswamy Drug binding in the undernourished: a study of the binding of propranolol to a1-acid glycoprotein Eur. J. Clin. Pharmacol. 27 1985 657 659
9. Y. Le Bloc'h, B. Woggon, H. Weissenrieder, D. Zullino, M. Brawand-Amey, J. Spagnoli, C.B. Eap, and P. Baumann Routine therapeutic drug monitoring in patients treated with 10-360 mg/day citalopram Ther. Drug Monit. 2003
10. E. Leinonen, U. Lepola, H. Koponen, and I. Kinnunen The effect of age and concomitant treatment with other psychoactive drugs on serum concentrations of citalopram measured with a nonenantioselective method Ther. Drug Monit. 18 1996 111 117
11. H. Lundbeck Kinetics of citalopram in man; plasma levels in patients Prog. Neuropsychopharmacol. Biol. Psychiatry 6 1982 311 318
12. S. Noble, and P. Benfield Citalopram-A review of its pharmacology, clinical efficacy and tolerability in the treatment of depression CNS Drugs 8 1997 410 431
13. K.F. Overø, B. Toft, L. Christopherson, and J.P. Glyding-Sabroe Kinetics of citalopram in elderly patients Psychopharmacology 86 1985 253 257
14. B.G. Pollock Citalopram: a comprehensive review Exp. Opin. Pharmacother. 2 2001 681 698
15. B.B. Rasmussen, and K. Brøsen Is therapeutic drug monitoring a case for optimizing clinical outcome and avoiding interactions of the selective serotonin reuptake inhibitors? Ther. Drug Monit. 22 2000 143 154
16. M. Reis, J. Lundmark, and F. Bengtsson Therapeutic drug monitoring of racemic citalopram: a 5-year experience in Sweden, 1992-1997 Ther. Drug Monit. 25 2003 183 191
17. E.A. Sotaniemi, A.J. Arranto, O. Pelkonen, and M. Pasanen Age and cytochrome P450-linked drug metabolism in humans: an analysis of 226 subjects with equal histopathologic conditions Clin. Pharmacol. Ther. 61 1997 331 339
18. C. Uehlinger, R. Nil, M. Amey, P. Baumann, and H. Dufour Citalopram-lithium combination treatment of elderly depressed patients: a pilot study Int. J. Pediatr. Psychiatry 10 1995 281 287